- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02796092
Fibered Platinum Coils vs Vascular Plugs in Pelvic Varices Embolization for the Treatment of Pelvic Congestion Syndrome
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Zaragoza, Spain, 50003
- Lozano Blesa University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Signed informed consent
- Presence of chronic abdominal or pelvic pain for more than 6 months
- >6 mm pelvic venous caliber measured by transvaginal US
- Presence of venous reflux OR presence of communicating veins assessed by transvaginal Doppler US
Exclusion Criteria:
- Diagnosed gynecological or pelvic pathology: endometriosis, pelvic inflammatory disease, postoperative adhesions, adenomyosis or leiomyoma
- Glomerular filtration rate <60 ml/min
- History of contrast reaction
- Patients not able to be followed up for at least one year
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Fibered platinum coils
Embolization of the pelvic veins with platinum fibered coils (Nester.
Cook Europe, Bjaeverskov, Denmark)
|
Other Names:
|
|
Experimental: Vascular plugs
Embolization of the pelvic veins with vascular plugs (Amplatzer Vascular Plugs II.
St. Jude Medical.
St. Paul, MN, USA)
|
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Pain Scale
Time Frame: 12 months
|
Reduction of 4 points or more between subjective pain assessed by VAS prior to procedure (-4, -5,- 6, -7,-8,-9). VAS= visual analogue scale: it is a subjective pain scale, scored from 1 to 10 (1 no pain; 10 worst pain possible) |
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Improvement of Dyspareunia
Time Frame: 12 months
|
Disappearance or improvement of dyspareunia assessed by direct questioning before the procedure and 12 months after the procedure (YES/NO)
|
12 months
|
|
Improvement of Urinary Urgency
Time Frame: 12 months
|
Disappearance or improvement of urinary urgency assessed by direct questioning before the procedure and 12 months after the procedure (YES/NO)
|
12 months
|
|
Improvement of Dysmenorrhea
Time Frame: 12 months
|
Disappearance or improvement of dysmenorrhea assessed by direct questioning before the procedure and 12 months after the procedure (YES/NO)
|
12 months
|
|
Satisfaction With the Procedure
Time Frame: 12 months
|
Overall satisfaction with the procedure via telephone survey (scaled from 0 to 9). Patients answered just one question. Are you satisfied with the procedure? Being 0 = Completely unsatisfied, I regret having undergone a embolization procedure 9=Totally satisfied with the procedure, everything was perfect, I would recommend it to anyone with the same problem. |
12 months
|
|
Number of Devices Used
Time Frame: intraoperative
|
Number of coils and number of vascular plugs used in each procedure
|
intraoperative
|
|
Cost of Treatment
Time Frame: Intraoperative
|
Cost of the differential devices used in each treatment procedure, assuming the same cost for the rest of the procedure, other material and hospital stay.
|
Intraoperative
|
|
Total Intervention Duration
Time Frame: Intraoperative
|
Total time length of the procedure, from puncture to compression (in minutes)
|
Intraoperative
|
|
Fluoroscopy Time
Time Frame: Intraoperative
|
Total fluoroscopy time, recorded by the equipment (in minutes)
|
Intraoperative
|
|
Procedure Radiation Dose (DAP)
Time Frame: Intraoperative
|
DAP, dose area product of the intervention, (in mGy*cm^2), recorded by fluoroscopy equipment
|
Intraoperative
|
|
Procedure Radiation Dose (AK)
Time Frame: Intraoperative
|
AK, total air kerma of the intervention (in mGy), recorded by fluoroscopy equipment
|
Intraoperative
|
|
Complications
Time Frame: intraoperative
|
Total number of events during the procedure
|
intraoperative
|
|
Complications
Time Frame: 12 months
|
Toral number of events related to the procedure in the follow-up (1 year)
|
12 months
|
|
Need for Re-embolization
Time Frame: 12 months
|
Scheduled re-embolization due to incomplete occlusion
|
12 months
|
Collaborators and Investigators
Investigators
- Principal Investigator: Miguel A De Gregorio, MD, PhD, Universidad de Zaragoza
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- GTM-01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pelvic Congestion Syndrome
-
Mark Magdy ZekryNot yet recruiting
-
Ain Shams UniversityRecruitingPelvic Congestion SyndromeEgypt
-
Interregional Clinical Diagnostic Center, RussiaCompletedPelvic Congestion SyndromeRussian Federation
-
Tanta UniversityRecruitingPelvic Congestion Syndrome | Glue EmbolizationEgypt
-
Assiut UniversityCompletedPelvic CongestionEgypt
-
Pirogov Russian National Research Medical UniversityCompletedPelvic Pain | Pelvic Congestion Syndrome | Varicose Veins PelvicRussian Federation
-
Group of Research in Minimally Invasive TechniquesUnknownObservational Study | Pelvic Congestion Syndrome | Embolization, Therapeutic | Pelvic Varicose Veins | Follow-up StudySpain
-
Kazan State Medical UniversityInterregional Clinical Diagnostic Center, RussiaCompletedPelvic Congestion SyndromeRussian Federation
-
ArtVentive Medical Group, Inc.UnknownVaricocele | Pelvic Congestion SyndromeBelgium, Poland, Switzerland
-
The Whiteley ClinicUnknownVaricose Veins | Venous Reflux | Pelvic Congestion SyndromeUnited Kingdom
Clinical Trials on Fibered platinum coils
-
Shanghai Shenqi Medical Technology Co., LtdCompletedPeripheral Arterial DiseaseChina
-
Centre hospitalier de l'Université de Montréal...DePuy Synthes; Johnson & Johnson Medical CompaniesCompletedDELTA Trial: Does Embolization With Larger Coils Lead to Better Treatment of Aneurysms Trial (DELTA)Cerebral AneurysmCanada, United States
-
Northwestern UniversityMicroVention, Inc.Completed
-
Stanford UniversityMauna Kea TechnologiesCompleted
-
Mercy Health OhioStryker NeurovascularUnknown
-
Kaneka Medical America LLCActive, not recruiting
-
Vanderbilt University Medical CenterStryker NeurovascularCompleted
-
Instituto Ecuatoriano de Enfermedades DigestivasCompleted
-
Assistance Publique Hopitaux De MarseilleCompletedHemorrhoidal DiseaseFrance
-
Boston Scientific CorporationPneumRx, Inc.CompletedEmphysemaUnited Kingdom, France, Germany, Netherlands, Italy, Austria